Safe lists for medications in pregnancy: inadequate evidence base and inconsistent guidance from Web-based information, 2011-Reference-Cited by-同舟云学术

Safe lists for medications in pregnancy: inadequate evidence base and inconsistent guidance from Web-based information, 2011

Published:2013-01-29 Issue:3 Volume:22 Page:324-328
ISSN:1053-8569
Container-title:Pharmacoepidemiology and Drug Safety
language:en
Short-container-title:Pharmacoepidemiol Drug Saf

Author:

Peters Stacey L.,Lind Jennifer N.,Humphrey Jasmine R.,Friedman Jan M.¹,Honein Margaret A.²,Tassinari Melissa S.³,Moore Cynthia A.²,Mathis Lisa L.³,Broussard Cheryl S.²

Affiliation:

1. Department of Medical Genetics; University of British Columbia; Vancouver; BC; Canada

2. NCBDDD; Centers for Disease Control and Prevention; Atlanta; GA; USA

3. Center for Drug Evaluation and Research; Food and Drug Administration; Silver Spring; MD; USA

Publisher

Wiley

Subject

Pharmacology (medical),Epidemiology

Reference12 articles.

1. Trust and sources of health information: the impact of the Internet and its implications for health care providers: findings from the first Health Information National Trends Survey;Hesse;Arch Intern Med,2005

2. Prescription medication borrowing and sharing among women of reproductive age;Petersen;J Womens Health (Larchmt),2008

3. Medication use during pregnancy, with particular focus on prescription drugs;Mitchell;Am J Obstet Gynecol,2011

4. Evolving knowledge of the teratogenicity of medications in human pregnancy;Adam;Am J Med Genet Part C Semin Med Genet,2011

5. Friedman JM Polifka JE 2011 TERIS. Micromedex reproductive risk information system (REPRORISK)

Cited by 40 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Reference guides for the safe use of drugs during pregnancy: a systematic review and comparative analysis;European Journal of Clinical Pharmacology;2024-08-26

2. Equitable Representation of Pregnant and Lactating Women in Clinical Research: A Historical Review and Critical Analysis of Proposed Legislation;American Journal of Perinatology;2024-04-17

3. Analysis of risk evaluation and mitigation strategies for teratogenic drugs: Variation in primary and secondary prevention measures;PLOS Medicine;2023-03-06

4. Prenatal exposure to teratogenic medications in the era of Risk Evaluation and Mitigation Strategies;American Journal of Obstetrics and Gynecology;2022-08

5. Information Needs and Counseling Preferences among Potential Users of the Future Teratology Information Service in Belgium: A Cross-Sectional Study Involving the Public and Healthcare Professionals;International Journal of Environmental Research and Public Health;2022-07-14